The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

State Public Health Data shows flu and RSV hospitalizations are rising. Officials say this season is similar to pre-COVID ...

The CDC reports that influenza A, COVID-19, norovirus, and RSV are on the rise this winter, with symptoms such as fever, ...

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...